Category:

...blockchain technology has moved from cryptocurrency to other fields…The Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare opened the Center for Biomedical Blockchain Research...with the aim of developing partnerships with companies looking to apply the technology to clinical medicine and biomedical research…Researchers have also been seeking to apply the technology to clinical trials...the British Medical Journal concluded that blockchain provides a significant opportunity for clinical research because it can help structure more transparent, checkable methodology and, under certain conditions, check clinical trial integrity...Imperial College London played host to a hackathon specifically to explore the use of blockchain in clinical trials...to replace the operations of contract research organizations...The two finalists proposed using distributed ledger technologies to operate all the necessary transactions between drug companies running trials and the clinical trial sites where they take place...

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

The need to improve visibility, enable faster study execution, and improve study quality, is driving the industry to unify its "broken" clinical trial operating environments, according to a report...nearly all respondents reported a need to unify clinical trial operating environments, and 87% said they have or plan to have, an initiative in motion to fulfill this need and improve trial performance...The main challenge of siloed applications and processes is integrating multiple applications...The top drivers for unification are to improve visibility (75%), enable faster study execution (61%), and improve study quality (60%)...The majority of respondents (84%) reported “significant deficiencies” with their current clinical trial management system (CTMS) applications, with more than 85% citing the inability to fully support functions such as governance and oversight, resource management, as well as issue and task management...industry is recognizing the need for key performance metrics (KPIs) and reporting capabilities “to learn about how they operate so that they can improve...recognizing they need a unified technology...

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Walgreens Boots Alliance is launching a new digital marketplace that will connect the pharmacy chain's mobile visitors to its drugstores as well as local doctors and clinics...The move comes as Walgreens, CVS Health, Walmart and other brick-and-mortar retailers with health services face the possibility online retailer Amazon will expand deeper into the healthcare business...But Walgreens is stressing ties to local healthcare providers, which Amazon doesn’t yet have...Walgreens “Find Care Now” platform lists cash prices for healthcare services for everything from a local clinic or optometrist to the cost of a telehealth vendor’s virtual doctor consultation. For now, there are 16 local health systems and national healthcare providers participating in Find Care Now but Walgreens said they expect more to join the marketplace.

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

The European Medicines Agency...published its first report on implementing its policy on the publication of clinical data whereby researchers, academics and others can access data from clinical reports submitted by pharmaceutical companies to EMA for new medicines as of 1 January 2015...The 27-page report covers one year from the launch of EMA’s clinical data website on 20 October 2016, and lists the 50 medicines for which clinical data were published...EMA is the only regulatory authority to provide open access to clinical data submitted by companies in support of their marketing authorisation applications...The report unveils the documents published, the amount of commercially confidential information redacted and the anonymization techniques used...EMA accepted about one third of CCI redactions proposed by pharmaceutical companies, though only 0.01% of 1.3 million pages published contained CCI redactions...anonymization techniques to protect personal data, the report suggests conducting a “proper assessment” of the impact of the anonymization technique on data utility and improving the quality of the anonymization reports...

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.